Skip to main content

Peer Review reports

From: Efficacy, safety, and biomarker analysis of first-line immune checkpoint inhibitors with chemotherapy versus chemotherapy for advanced gastric cancer: a multicenter, retrospective cohort study

Original Submission
9 May 2024 Submitted Original manuscript
22 Jun 2024 Reviewed Reviewer Report - Akira Ooki
30 Jun 2024 Reviewed Reviewer Report
27 Jul 2024 Reviewed Reviewer Report
10 Oct 2024 Author responded Author comments - Lian Liu
15 Oct 2024 Reviewed Reviewer Report
16 Oct 2024 Reviewed Reviewer Report
17 Oct 2024 Reviewed Reviewer Report - Akira Ooki
18 Nov 2024 Author responded Author comments - Lian Liu
Resubmission - Version 2
10 Oct 2024 Submitted Manuscript version 2
Publishing
27 Nov 2024 Editorially accepted
18 Dec 2024 Article published 10.1186/s12916-024-03801-5

You can find further information about peer review here.

Back to article page